The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between rosuvastatin and fenofibric acid in healthy adult subjects
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
30
tablet, rosuvastatin 20mg
capsule, fenofibric acid 135mg
rosuvastatin 20mg, Fenofibric acid 135mg
Inje University College of Medicine Busan Paik Hospital
Busan, South Korea
Cmax
Time frame: Multiple blood sample will be collected for 24 hours after last dosing in each of the periods
AUCtau
Time frame: Multiple blood sample will be collected for 24 hours after last dosing in each of the periods
Cmin
Time frame: Multiple blood sample will be collected for 24 hours after last dosing in each of the periods
Tmax
Time frame: Multiple blood sample will be collected for 24 hours after last dosing in each of the periods
CL/F
Time frame: Multiple blood sample will be collected for 24 hours after last dosing in each of the periods
T1/2
Time frame: Multiple blood sample will be collected for 24 hours after last dosing in each of the periods
Metabolic Ratio
Time frame: Multiple blood sample will be collected for 24 hours after last dosing in each of the periods
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.